Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-011303
Date:2020-02-18
Issuer: INTRA-CELLULAR THERAPIES, INC. (ITCI)
Original Submission Date:

Reporting Person:

SATLIN ANDREW
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET NEW YORK, NY 10016

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 23.94 2020-02-18 deemed execution date A 26,754 (a) 2030-02-17 common stock 26,754 $23.94 26,754 direct
RESTRICTED STOCK UNITS 0.0 2020-02-18 deemed execution date A 33,417 (a) common stock 33,417 $0.00 33,417 direct
Footnotes
IDfootnote
f1 on february 18, 2020, the reporting person was granted options to purchase 26,754 shares of common stock, vesting in three equal annual installments beginning on the first anniversary of the grant date.
f2 each restricted stock unit represents a contingent right to receive one share of common stock.
f3 on february 18, 2020, the reporting person was granted 33,417 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
WhaleWisdom Logo

Elevate your investments